TGFB1 and type 1 diabetes mellitus: Acute treatment of late stage autoimmune pre-diabetic NOD mice with the combined RA/TGFβ/T1D-relevant autoantigen microparticle formulation resulted in a mild increase in the frequency of regulatory B-lymphocytes (Bregs) inside the mesenteric lymph nodes (MLN), but not the PLN.